Advertisement

Topics

Ironwood Announces FDA Approval Of DUZALLO (Lesinurad And Allopurinol) For The Treatment Of Hyperuricemia In Patients With Uncontrolled Gout

20:00 EDT 20 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Ironwood Announces FDA Approval Of DUZALLO (Lesinurad And Allopurinol) For The Treatment Of Hyperuricemia In Patients With Uncontrolled Gout

NEXT ARTICLE

More From BioPortfolio on "Ironwood Announces FDA Approval Of DUZALLO (Lesinurad And Allopurinol) For The Treatment Of Hyperuricemia In Patients With Uncontrolled Gout"

Advertisement
Quick Search
Advertisement
Advertisement